[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364305-105":59,"doc-detail-364305-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibition-of-klf5-promotes-ferroptosis-via-the-zeb1hmox1-axis-to-enhance-sensitivity-to-oxaliplatin-in-cancer-cells","Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells","","Inhibition of KLF5 is investigated as a way to trigger ferroptosis and improve chemotherapy response in pancreatic cancer. The study links KLF5 repression to decreased HMOX1 expression through a ZEB1-mediated mechanism. Pharmacologic or inhibitory targeting of KLF5 markedly increases oxaliplatin cytotoxicity in vitro and suppresses tumor growth in vivo compared with either oxaliplatin treatment alone. Results support KLF5 as a key sensitization node for platinum-based chemotherapy via ferroptosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibition-of-klf5-promotes-ferroptosis-via-the-zeb1hmox1-axis-to-enhance-sensitivity-to-oxaliplatin-in-cancer-cells/364305/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibition-of-klf5-promotes-ferroptosis-via-the-zeb1hmox1-axis-to-enhance-sensitivity-to-oxaliplatin-in-cancer-cells/364305.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of inhibiting KLF5 in this study?","Question",{"text":112,"@type":113},"To determine whether blocking KLF5 can promote ferroptosis and thereby enhance the sensitivity of cancer cells to oxaliplatin, particularly in pancreatic cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does KLF5 inhibition influence ferroptosis-related signaling?",{"text":117,"@type":113},"KLF5 inhibition reduces HMOX1 expression by repressing ZEB1, which facilitates the ferroptotic cytotoxic effect.",{"name":119,"@type":110,"acceptedAnswer":120},"What treatment outcome does the combination of oxaliplatin with a KLF5 inhibitor produce?",{"text":121,"@type":113},"It significantly potentiates cell death in vitro and inhibits tumor growth in vivo compared with oxaliplatin treatment alone.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364305,1790887566,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nInhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells  \nZheng Zhang 1,2,3,7, Huaxiang Xu1,2,3,7, Junyi He1,2,3,7, Qiangsheng Hu4,7, Yuxin Liu5, Zijin Xu6, Wenhui Lou 1,2,3, Wenchuan Wu1,2,3, Lei Zhang1,2,3, Ning Pu1,2,3, Chenye Shi1,2,3, Yaolin Xu 1,2,3, Wenquan Wang 1,2,3 ✉ and Liang Liu 1,2,3 ✉  \n© The Author(s) 2025  \n\n|  | As a novel form of nonapoptotic cell death, ferroptosis is developing into a promising therapeutic target of dedifferentiating and therapy-refractory cancers. However, its application in pancreatic cancer is still unknown. In the preliminary research, we found that F-box and WD repeat domain-containing 7 (FBW7) inhibited the migration and proliferation of pancreatic cancer cells through its substrate c-Myc. We further found that another key substrate of FBW7, KLF5, could inhibit ferroptosis. Inhibiting KLF5 signiﬁcantly enhances the cytotoxicity of oxaliplatin rather than other chemotherapy drugs. Mechanistically, we found that KLF5 inhibited the expression of heme oxygenase 1 (HMOX1) via repressing zinc ﬁnger E-box-binding homeobox 1 (ZEB1) . Inhibition of KLF5 facilitated the cytotoxic effect of oxaliplatin via promoting ferroptosis. Oxaliplatin combined with KLF5 inhibitor signiﬁcantly potentiated cell death in vitro and inhibited tumor growth in vivo compared with either treatment alone. These results reveal a critical role of KLF5 in sensitized chemotherapy of pancreatic cancer, and suggest that ferroptosis combined with platinum-based |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| chemotherapy rather than gemcitabine-based chemotherapy is expected to bring better therapeutic effects. |  |  |\n|  | Cell Death and Disease (2025)16:28; [https://doi.org/10.1038/s41419-025-07330-8](https://doi.org/10.1038/s41419-025-07330-8) |  |\n|  |  |  |\n\nINTRODUCTION  \nPancreatic ductal adenocarcinoma (PDAC) is projected to be the second leading cause of cancer-related mortality by 2040 [1, 2] . Surgery and chemotherapy are the primary treatment strategies for PDAC. However, radical surgery can only be performed on 15–20% of patients, owing to the high incidence of distant metastasis at diagnosis. Less than 50% of patients are sensitive to chemotherapy [3, 4] . Moreover, chemotherapy has a limited effect on the survival of advanced pancreatic cancer and chemotherapy resistance is an important cause. Therefore, thereis an urgency to develop novel strategies that sensitize cancer cells to chemotherapy.  \nOur prior study found that FBW7 regulated pancreatic cancer cell proliferation and metastasis through the substrate c-Myc [5] . Accumulating evidence has demonstrated that FBW7 acts as a crucial tumor suppressor by mediating the degradation of multiple substrates, including KLF5 [6, 7] . KLF5 belongs to the Krüppel-like factor family, which are evolutionarily conserved zinc ﬁnger-containing transcription factors with multiple regulatory functions in diverse human cancers [8] . KLFs regulate cancer cell apoptosis and proliferation, metastasis, cancer stem cells, and tumor microenvironment [9] . Emerging evidence has also identiﬁed KLF5 as an oncoprotein in various human malignancies, such as esophageal squamous carcinoma [10], colorectal cancer [11], prostate cancer [12], esophageal adenocarcinoma [13], and lung cancer [14] . KLF5 plays a crucial role in the carcinogenesis  \nand development of PDAC. David et al. reported that KLF5 assisted Sox4 in tumorigenesis and repressed Sox4-induced apoptosis in PDAC [15] . Ablation of KLF5 in pancreatic cancer cells can alter the tumor immune microenvironment and sensitize tumors cells to combination immunotherapy [16] . KLF5 is also involved in proliferation, glycolysis, and immune cell inﬁltration of PDAC [17, 18] . However, the role of KLF5 in PDAC ferroptosis remains unclear.  \nFerropt","cbCaifFraTjB99pT","https://ap.wps.com/l/cbCaifFraTjB99pT","pdf",5754484,15,"English","# Introduction\n# Background on ferroptosis and pancreatic cancer\n# Role of FBW7 and KLF5 in PDAC\n# Study rationale and mechanistic focus","[{\"question\":\"What is the main goal of inhibiting KLF5 in this study?\",\"answer\":\"To determine whether blocking KLF5 can promote ferroptosis and thereby enhance the sensitivity of cancer cells to oxaliplatin, particularly in pancreatic cancer.\"},{\"question\":\"How does KLF5 inhibition influence ferroptosis-related signaling?\",\"answer\":\"KLF5 inhibition reduces HMOX1 expression by repressing ZEB1, which facilitates the ferroptotic cytotoxic effect.\"},{\"question\":\"What treatment outcome does the combination of oxaliplatin with a KLF5 inhibitor produce?\",\"answer\":\"It significantly potentiates cell death in vitro and inhibits tumor growth in vivo compared with oxaliplatin treatment alone.\"}]","Inhibition of KLF5 promotes ferroptosis via the ZEB1/HMOX1 axis to enhance sensitivity to oxaliplatin in cancer cells | PDF",1790156837,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94cd70accc37baf0b820ec6adece3557.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4e552aef558cc99179bab53b11c1c81.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/35467ecec6257d1ccf3da4a4bfea03cf.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c715cd4c020b77a518c0ac85eb11ee9.webp",980,1301]